Booth RE, Lehman WE, Brewster JT, Sinitsyana L, Dvoryak S. Gender differences in sex risk behaviors among Ukraine injection drug users. Journal of the Acquired Immune Deficiency Syndromes. In press.
Booth RE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S. Predictors of HIV sero-status among drug injectors at three Ukraine sites.AIDS. 2006;20:2217-2223.
Booth RE, Kwiatkowski CF, Mikulich-Gilbertson SK, Brewster JT, et al. Predictors of risky needle use following interventions with drug injectors in Ukraine. Drug and Alcohol Dependence. 2006;82:S49-S55.
Booth RE, Corsi, KF, Mikulich-Gilbertson SK. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug and Alcohol Dependence. 2004;74:177-185.
Booth RE, Mikulich-Gilbertson SK, Brewster JT, Salomonson-Sautel S, Semerik O. Predictors of self-reported HIV infection among drug injectors in Ukraine. Journal of the Acquired Immune Deficiency Syndromes. 2004;35:82-88.
Booth RE, Kennedy JK, Brewster JT, Semerik O. Drug injectors and dealers in Odessa, Ukraine. Journal of Psychoactive Drugs. 2003;35:419-426.
Booth RE, Corsi KF, Mikulich SK. Improving treatment to methadone maintenance among out-of-treatment drug users. Journal of Substance Abuse Treatment. 2003;24:305-311.
Booth RE, Crowley TJ, Zhang Y. Substance abuse treatment entry, retention and effectiveness: Out-of-treatment opiate injection drug users. Drug and Alcohol Dependence. 1996;42:11-20.
Booth RE. Predictors of unsafe needle practices: Injection drug users in Denver. Journal of the Acquired Immune Deficiency Syndromes. 1994;7:504-508.
Booth RE, Watters JK. How effective are risk-reduction interventions targeting injecting drug users? AIDS. 1994;8:1515-1524.
Booth RE, Watters JK, Chitwood DD. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack.
American Journal of Public Health. 1993;83:1144-1148.
Title: Intervention to Reduce Injection Drug Use
The goal of this study is to assess the relative effectiveness of three intervention strategies in reducing HIV-related risk behavior and facilitating entrance into substance abuse treatment.
Role: Principal Investigator
RO1 DA09832-11
NIH/NIDA
Dates: 7/15/1995 - 06/30/2012
Title: Interventions with HIV+ and HIV- IDUs in Ukraine
This study is designed to assess the relative effectiveness of HIV testing and counseling alone compared to testing and counseling combined with street outreach interventions in reducing HIV-related risk behaviors. The project will take place in three Ukraine citing, Kiev, Odessa and Makeevka/Donetsk.
Role: Principal Investigator
RO1 DA017620-04
NIH/NIDA
Dates: 9/30/2003 - 6/30/2008
Title: Reducing HCV/HIV Risks Comparing Two Interventions
The goal of this study is to assess a peer-led intervention model compared to an intervention that stresses individual risk assessments in reducing HIV-related risk behaviors.
Role: Principal Investigator
RO1 DA016994-04
NIH/NIDA
Dates: 9/01/2003 - 6/30/2008
Title: Reduction of HIV Risk and Drug Use Among Out-of-Treatment Methamphetamine Users
The major goal of this grant is to induce methamphetamine users to reduce their HIV risk behaviors and drug use.
Role: Co-Investigator; Corsi (PI)
1R21DA021522-01
NIH/NIDA
Dates: 5/10/2006-3/31/2008
Title: Interventions with HIV+ and HIV- IDUs in Ukraine
The overall goal of this administrative supplement application is to initiate a pilot study designed to compare the relative effectiveness of two interventions in reducing HIV-related risk behaviors among IDUs in two Ukraine cities (Simferopol and Nikolayev).
Role: Principal Investigator
RO1 DA017620-03S1
NIH/NIDA
Dates: 07/01/2005 - 6/30/2007
Title: A Supplemental Application to Assess Interventions to Reduce Injection Drug Use
The major goal of this grant is to recruit African-American IDUs and compare three different interventions, including motivational interviewing, risk reduction and case management, to see what facilitates treatment entry and reduction of HIV risk behaviors.
Role: Principal Investigator
5R01DA09832-07A1
NIH/NIDA
Dates: 8/1/02 - 05/31/2005
Title: Rocky Mountain Regional Clinical Trials Node
This project is intended to conduct studies of behavioral, pharmacological, and integrated behavioral and pharmacological treatment inventions of therapeutic effect in rigorous, multisite clinical trials to determine effectiveness across a broad range of community-based treatment settings and diversified patient populations.
Role: Co-Investigator; Riggs (PI)
U10DA13716-03
NIH/NIDA
Dates: 9/30/2000-8/31/2005
Title: Antecedents to Risk Behaviors among Drug Users
The goal of this investigation is to determine social, personal, pharmacological and environmental antecedents to HIV risk behaviors among injection drug users, crack smokers and non-drug users.
Role: Principal Investigator
RO1 DA12813-05
NIH/NIDA
Dates: 8/1/99 - 7/31/2004
Title: A Supplemental Application Designed to Assess the Contribution of Psychiatric Co-Morbidity to HIV-Related Risk-Taking Behaviors.
The major goal of this grant is to examine psychiatric co-morbidity and how that relates to HIV-related risk taking among IDUs.
Role: Principal Investigator
5R01DA12813-03
NIH/NIDA
Dates: 8/01/02 - 7/31/2004
Title: HIV Risk in Drug Users: Relapse and Maintenance Behavior
This longitudinal project is designed to assess current risk behaviors of clients originally recruited 7-10 years ago for NIDA’s Cooperative Agreement.
Role: Principal Investigator
RO1 DA12322-05
NIH/NIDA
Dates: 02/10/1999 - 01/31/2004
Title: Collaborative Research to Assess Antecedents to Risk Behaviors Among Opiate Injectors in Odessa, Ukraine. This pilot project is designed to develop an intervention that address the practice opiate users have in Odessa of purchasing opiates in “pre-loaded” syringes.
Role: Principal Investigator
RO1 DA12813-03S1
NIH/NIDA
Dates: 8/01/2001 - 7/31/2003
Title: A Supplemental Application to Establish Collaborative Research to Reduce Injection Use in Ukraine
The overall goal of this pilot project is to test the efficacy of a street outreach intervention in three Ukraine cities in reducing HIV-related risk behaviors.
Role: Principal Investigator
RO1 DA09832-07S1
NIH/NIDA
Dates: 6/01/2001 - 5/31/2003
Title: Over the Counter Syringe Purchase in Five Communities
The major goal of this grant was to look at over-the-counter syringe access in rural and urban setting in four states and to compare rates of purchase by gender, ethnicity, and rural vs. urban.
Role: Co-Investigator
R01DA12340
NIH/NIDA
Dates: 3/1/99 - 3/31/01
Title: HIV Seroincidence Study
The goal of this study was to examine hepatitis rates in a high-risk population (i.e., injection drug users).
Role: Principal Investigator
Contract #00-00166
Colorado Department of Public Health and Environment
Dates:1/1/99 - 12/31/01
Title: Community Outreach to Injection Drug Users.
The goal of this study was to recruit injection drug users through street and community outreach in order to deliver interventions intended to reduce drug and sex-related risk behaviors.
Role: Principal Investigator
Contract #706312
Colorado Department of Public Health and Environment
Dates: 1/1/98 - 12/31/99
Title: The Prevalence of Hepatitis B and C in Drug Users
The goal of this study was to provide HIV and hepatitis B and C testing and counseling among injecting drug users and to assess the seroprevalence of these diseases.
Role: Principal Investigator
Contract #FHAEP198000069
Colorado Department of Public Health and Environment
Dates: 1/1/98 - 12/31/98
Title: Community AIDS Prevention: A Cross-Over Study
The goal of this cooperative agreement was to assesses the effect of site-developed enhanced interventions designed to reduce HIV-related risk behaviors compared to a NIDA-developed standard intervention.
Role: Principal Investigator
U01DA06912
NIH/NIDA
Dates: 9/1/90 - 8/31/95
